Phillips Medisize, a Molex company, has announced the launch of TheraVolt™, a new line of medical connectors engineered to support advanced device integration, performance, and reliability in electrophysiology (EP) applications. This is the first connector product line released under the
Phillips Medisize, a company designing and manufacturing innovative products for the pharmaceutical drug delivery, in vitro diagnostic and medtech markets, has finalised the acquisition of Vectura Group Ltd. from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International Inc.
Molex has signed an agreement to acquire Vectura Group Limited, a inhalation drug device developer based in Chippenham, UK. The acquisition, made through its subsidiary Phillips Medisize, will expand Molex’s ability to offer innovative solutions for pharmaceutical customers, particularly in
